RSS
EGRX
Rosenblum Silverman Sutton’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q1 | – | Sell |
-5,790
| Closed | -$309K | – | 69 |
|
2017
Q4 | $309K | Hold |
5,790
| – | – | 0.11% | 65 |
|
2017
Q3 | $345K | Buy |
5,790
+1,125
| +24% | +$67K | 0.13% | 60 |
|
2017
Q2 | $368K | Buy |
4,665
+400
| +9% | +$31.6K | 0.15% | 59 |
|
2017
Q1 | $354K | Sell |
4,265
-25
| -0.6% | -$2.08K | 0.15% | 59 |
|
2016
Q4 | $340K | Sell |
4,290
-725
| -14% | -$57.5K | 0.16% | 58 |
|
2016
Q3 | $351K | Buy |
+5,015
| New | +$351K | 0.16% | 60 |
|
2015
Q4 | $1.98M | Hold |
22,375
| – | – | 0.91% | 41 |
|
2015
Q3 | $1.66M | Buy |
22,375
+8,435
| +61% | +$624K | 0.79% | 42 |
|
2015
Q2 | $1.13M | Buy |
+13,940
| New | +$1.13M | 0.45% | 53 |
|